| Patients with T2D N = 48 | Control subjects N = 48 | p |
---|---|---|---|
General characteristics | |||
 Male, n (%) | 31 (65) | 31 (65) | 1 |
 Age, years: mean (SD) | 64.8 (12.8) | 64.7 (12.8) | 0.2 |
 BMI, kg/m2: mean (SD)a | 27.7 (5.9) | 23.8 (4.9) | < 0.001 |
Cardiovascular risk factors | |||
 Hypertension, n (%)b | 30 (63) | 13 (29) | 0.013 |
 Dyslipidemia, n (%)c | 32 (76) | 11 (31) | < 0.0001 |
 Coronary disease, n (%)d | 13 (28) | 4 (9) | 0.05 |
 Estimated glomerular filtration rate, mL/min: mean (SD)e | 85.9 (30.3) | 94.9 (23.6) | 0.2 |
 Renal failure, n (%)e | 9 (19) | 3 (7) | 0.2 |
 Severe renal failure, n (%)e | 1 (2) | 0 (0) | 1 |
 Tobacco use (current or stopped for less than 3 years), n (%)f | 11 (25) | 6 (19) | 0.6 |
Diabetes characteristics | |||
 HbA1c, mmol/mol: median (IQR)g | 58 (48–76) | 34 (33–42) | NA |
 HbA1c, %: median (IQR)g | 7.5 (6.5–9.1) | 5.3 (5.2–6) | NA |
 Diabetes duration, years: median (IQR)h | 10 (5.5–17.3) |  |  |
 Insulin use, n (%) | 19 (40) |  |  |
 Neuropathy, n (%)i | 15 (52) |  |  |
 Nephropathy, n (%)j | 15 (47) |  |  |
 Retinopathy, n (%)k | 11 (42) |  |  |